Načítá se...
Rheumatic disease and COVID-19: epidemiology and outcomes
Since the outset of the COVID-19 pandemic, numerous risk factors for severe disease have been identified. Whether patients with rheumatic diseases, especially those receiving DMARDs, are at an increased risk of SARS-CoV-2 infection or severe COVID-19 disease remains unclear, although epidemiological...
Uloženo v:
| Vydáno v: | Nat Rev Rheumatol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747184/ https://ncbi.nlm.nih.gov/pubmed/33339986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41584-020-00562-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|